Spark backs Zilico with additional £750,000

The GP originally backed the firm in June this year with £1m, in order to support Zilico's international expansion and the manufacturing of commercial devices.

Spark invested through The North West Fund for Biomedical, a £25m vehicle launched in February 2011. The vehicle is a sub-fund of the £185m evergreen North West Fund financed by the European Investment Bank and the European Regional Development Fund.

The firm will use the funding to support its move to Manchester and its expansion into Europe.

Company
Founded in 2006 as a spinout of the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, Zilico has developed technology to speed up and improve the cervical cancer diagnosis process.

The company will be based in Manchester.

People
Penny Attridge is a senior investment director at Spark.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• Healthcare
• UK / Ireland
• United Kingdom